SCHEMBL24310323

SCHEMBL24310323

CN/C=C(\C=N)SNc1nc(Oc2ccccc2C)cc(C2CC2c2ccccc2)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309724 0.80 — —
SCHEMBL26807639 0.73 TSHR (0.47) —
SCHEMBL24310336 0.72 GPR39 (0.33) —
SCHEMBL24310117 0.72 AURKB (0.33) —
SCHEMBL29566989 0.72 NUDT1 (0.43) —
SCHEMBL24309816 0.72 NUDT1 (0.43) —
SCHEMBL24310321 0.72 NUDT1 (0.43) —
SCHEMBL24309395 0.70 — —
SCHEMBL24310554 0.69 F10 (0.34) —
SCHEMBL24310676 0.68 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback